Neurotechnology Market

Neurotechnology Market Overview

The neurotechnology market size is projected to grow from USD 15.1 billion in 2024 to USD 58.51 billion by 2035, representing a CAGR of 13.1%, during the forecast period till 2035.

To learn more about this report, request a free sample copy

The new research study consists of industry analysis, detailed neurotechnology market analysis, mega trends, patent analysis, porter five forces, SWOT analysis, value chain analysis and other strategic frameworks.

Currently, more than 80% of deaths and health issues related to neurological conditions take place in low- and middle-income countries. This signifies the groundbreaking fusion of neurological disorders and technological advancements. It is worth highlighting that neurotechnology poised a range of technologies designed to interface with the nervous system, enabling the monitoring and modulation of neural activity through devices such as advancements in brain-computer interfaces. Few of the major advantages of neurotechnology include improved patient outcomes for conditions like Alzheimer's disease, epilepsy, and other neurological impairments, while also advancing research in neuroscience. Furthermore, neurotechnology has transformed operations by providing deeper insights and more efficient solutions to pressing problems for various industries including healthcare, education and information technology.

The neurotechnology market is emerging as a critical component in the global shift towards innovation and digital transformation to reach higher work efficiency. Artificial intelligence (AI) and machine learning has played a pivotal role in unlocking full neurotechnology market potential, which improves quick responses and treatment condition. Additionally, the emergence of brain-computer interfaces (BCIs), which allow for direct communication between the brain and external devices, facilitating improved control over prosthetics and aiding rehabilitation for individuals with neurological impairments. Consequently, with continuous technological advancements and rising investors, future trends in neurotechnology are anticipated to witness noteworthy growth during this forecast period.

Recently in October 2024, Cambridge Network participated in a multi-million-pound, three-year program with the UK Government's Advanced Research and Invention Agency (ARIA) to advance neurotechnologies aimed at treating conditions like depression and epilepsy. While addressing about the collaboration John Gourd, CEO of Cambridge Network mentioned companies already active in the neurotechnology sector, we are eager to partner with organizations that possess technologies in other domains that could be adapted for this field, as well as those looking to enter the neurotechnology market.

Neurotechnology Market Share Insights

The neurotechnology market research report presents an in-depth analysis of the various service providers that are involved in offering neurotechnology market, across different segments, as defined in the table below:

Neurotechnology Market: Report Attributes / Market Segmentations

Neurotechnology Market Segmentation

Market Share by Type of Product

Based on the type of product, the global neurotechnology market is split into cranial surface measurement, neuroprosthetics, neurorehabilitation, neurosensing, neurostimulation and others. Among the categories, the neuroprosthetics segment is expected to gain nearly 35% of the current market share. Further, this segment is expected to expand with a relatively higher (15.45%) CAGR till 2035. Prominent reasons for this dominance include due to the rising prevalence of neurological disorders treatment technologies, such as Parkinson's disease, epilepsy, and spinal cord injuries, which necessitate innovative solutions for restoring lost functions.

Market Share by Type of Condition

The global neurotechnology market is segmented into various type of condition, such as cognitive disorders, epilepsy, pain treatment, Parkinson, urinary and fecal incontinence and others. According to our analysis, the pain treatment segment will augment the segment's growth with the largest neurotechnology market share of around 45% by 2035. This can be attributed to advancements in neurotechnological innovations, such as neuromodulation devices and targeted therapies that offer improved efficacy and patient pain treatment. However, the epilepsy segment is expected to grow with a relatively higher of CAGR of 14.56% till 2035. Prominent reasons include increasing prevalence of the condition, which affects over 50 million people worldwide, alongside many undiagnosed cases.

Market Share by End-User

The global neurotechnology market is fragmented into multiple end-users, namely homecare facilities, hospital, surgical centers and others. The hospital segment is anticipated to dominate the segment with the highest neurotechnology market share of 40% over the next decade. Additionally, this segment is expected to grow with a relatively higher CAGR in the forecasted period. This can be ascribed to their advanced infrastructure and specialized personnel, enabling them to perform complex neuromodulation procedures for a variety of neurological disorders.

Market Share by Type of Enterprise

Based on the types of enterprise, the global neurotechnology market is segmented into large and small and medium enterprise. According to our analysis, the large-scale enterprises are leading the segment with the 65% market share and are expected to growth with a relatively higher `CAGR in the forecasted period. This can be attributed to its capacity to invest in advanced neurotechnology, benefit from substantial resources, increase economies of scale, and drive business growth.

Market Share by Geographical Regions

This segment highlights the distribution of neurotechnology across various geographical regions, such as North America, Europe, Asia, Latin America, Middle East and North Africa, and the rest of the world. According to our analysis, the North America neurotechnology market exhibits dominance with the majority of the neurotechnology market share, nearly 35% in the global marketplace. However, Asia is expected to grow with a relatively higher (15.74%) CAGR. This can be attributed to increasing healthcare spending, heightened public awareness about neurological health, and proactive government initiatives aimed at modernizing healthcare systems, particularly in countries like China and India.

Neurotechnology Market Key Insights

The “Neurotechnology Market, Till-2035: Industry Trends and Global Forecasts” report features an extensive study of the current market landscape, market size and future opportunity within their neurotechnology market dynamics, during the given forecast period. The market report highlights the efforts of several stakeholders involved in this rapidly emerging segment of the service providers industry. Key takeaways of the neurotechnology market report are briefly discussed below.

Key Drivers of Neurotechnology Market

The demand for technological advancements in every industry is increasing, which will mark neurotechnology market to be a crucial innovation in the greater acceptance of neurotechnological interventions. Key driving factors include the increasing prevalence of neurological disorders, increased investment opportunities in neurotechnology from public and private sectors fostering innovation, and heightened research funding from public and private sectors. Additionally, the rising healthcare expenditures, the adoption of precision medicine and telemedicine further drive demand for innovative solutions. Notably, the ability to innovate through strategic partnerships among institutions and players will be the key to success during this forecast period.

Neurotechnology Competitive Landscape

With the presence of several small and large neurotechnology companies, the market is experiencing intense competition and changing market dynamics. From large multinational companies to local neurotechnology players, companies are striving to enhance their competitive edge. In terms of market share, large enterprises and multinational companies are dominating the market. While small neurotechnology players are continuously improving their products to cater to niche markets, or they are offering specialized services. These industry players are focusing on adopting competitive strategies, such as developing innovative neurotechnology, forming strategic alliances and partnerships to expand their portfolios and global footprint, investing in recent developments and new feature launches to enhance their neurotechnology offerings.

Market Challenges in Neurotechnology Market

Despite strong market growth projection, neurotechnology market faces numerous challenges, including technical limitations such as a limited understanding of brain function, difficulties in device integration. Notably, high technological complexity, as neurotechnology requires deep expertise in neuro mechanics, alongside sophisticated hardware capable of functioning at extremely low temperatures. Additionally, regulatory hurdles arise from a complex landscape that complicates the approval process for both consumer and medical technologies. Addressing these challenges mentioned is essential for expansion of neurotechnology market growth in the near future.

Regional Analysis: North America is Expected to Dominate the Market with the Largest Neurotechnology Market Share

With respect to regional neurotechnology market insights, North America is likely to dominate the market for neurotechnology with a 40% market share. Primarily, due to high prevalence of neurological disorders, advanced healthcare infrastructure, and significant investments in research and development. The region's robust ecosystem of leading universities and research institutions contributes to advancements in neurotechnology. Additionally, the presence of major industry players such as Medtronic and Abbott drives market growth through the introduction of new products and increased public awareness.

Key Players in Neurotechnology

Examples of key players involved in the neurotechnology market (which have also been captured in this market report, arranged in alphabetical order) include Abbott Laboratories, Allengers Medical Systems, Elekta, GE HealthCare Technologies, Hitachi Medical, Koninklijke Philips, Magstim, Medtronic, Natus Medical, Neuralink, Shimadzu, Siemens Healthcare, Toshiba Medical Systems and Tristan Technologies. This market report includes an easily searchable excel database of all the companies who are in neurotechnology market.

Neurotechnology Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain, across different segments. Amongst other elements, the market report includes:

• A preface providing an introduction to the full report, neurotechnology market, since 2019 (Historical Trends) and till-2035 (Forecasted Estimates).
• An outline of the systematic research methodology adopted to conduct the study on the neurotechnology market, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure the accuracy and reliability of our findings.
• An overview of economic factors that impact the overall neurotechnology market, including historical neurotechnology market trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
• An executive summary of the insights captured during our research. It offers a high-level view on the current state of the neurotechnology market and its likely evolution in the mid-long term.
• A detailed assessment of the neurotechnology market landscape, based on several relevant parameters, including year of experience, company size, location of headquarters, and ownership structure.
• Elaborate profiles of prominent players engaged in the neurotechnology market, featuring information on their year of establishment, location of headquarters, company size, company mission, company footprint, management team, contact details, financial information, operating business segments, neurotechnology portfolio, moat analysis, recent developments, and an informed future neurotechnology market outlook.
• A qualitative assessment of the various megatrends ongoing in the global neurotechnology industry, including integration of quantum computing with AI, rapid growth in machine learning applications and the emergence of quantum cloud services.
• An analysis highlighting the key unmet needs across global neurotechnology market trends, featuring insights generated from real-time data on unmet needs as identified from social media posts, recent publications, industry blogs and the views of key opinion leaders expressed on online platforms.
• An in-depth analysis of various patents that have been filed / granted related to neurotechnology and its components, based on various parameters, such as type of patent, patent publication year, patent age and leading players
• A detailed analysis of recent developments in the neurotechnology domain, based on relevant parameters such as year of initiative, type of initiative (partnerships and collaborations, expansions, funding and product launches), geographical distribution and most active players (in terms of number of recent developments).
• Key winning strategies framework that helps in analyzing the level of neurotechnology market competition within an industry, by tracing the key market activities including partnership, funding, expansion of leading players
• A qualitative analysis, highlighting the five competitive forces prevalent in neurotechnology industry, including threats for new entrants, bargaining power of suppliers, bargaining power of customers, threats of substitution and rivalry among existing competitors.
• A discussion on affiliated global neurotechnology trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall neurotechnology market.
• A value chain analysis featuring a discussion on various stakeholders involved in the development of the neurotechnology market, from suppliers to end-users.
• A detailed estimate of the current market size and the future growth potential of the neurotechnology market over the next decade. Based on multiple parameters we have provided an informed estimate on the market evolution during the forecast period 2024-2035. The report also features the likely distribution of the current and forecasted opportunity within the neurotechnology market. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
• Detailed projections of the current and future market across various type of product such as cranial surface measurement, neuroprosthetics, neurorehabilitation, neurosensing, neurostimulation and others.
• Detailed projections of the current and future market across various type of condition such as cognitive disorders, epilepsy, pain treatment, parkinson, urinary and fecal incontinence and others.
• Detailed projections of the current and future market across various end-user such as homecare facilities, hospital, surgical centers and others.
• Detailed projections of the current and future market across various types of enterprise such as large and small and medium enterprise.
• Detailed projections of the current and future neurotechnology market across various geographical regions, such as North America (US, Canada, Mexico and other North American countries), Europe (Austria, Belgium, Denmark, France, Germany, Ireland, Italy, Netherlands, Norway, Russia, Spain, Sweden, Switzerland, UK and other European countries), Asia (China, India, Japan, Singapore, South Korea and other Asian countries), Middle East and North Africa (Egypt, Iran, Iraq, Israel, Kuwait, Saudi Arabia, UAE and other MENA countries), Latin America (Brazil, Chile, Colombia, Venezuela and other Latin American countries) and rest of the world (Australia, New Zealand and other countries).

Recent Development Neurotechnology Market

• In August 2024, Cerebro NeuroTech, partnered with the Birmingham nonprofit Lakeshore Foundation. The collaboration aimed to address gaps in medical research that often excludes disabled individuals, fostering a more inclusive approach to applications of neurotechnology.
• In July 2024, Cranius secured $1 million in funding to enhance its neurotechnology platform, which focuses on developing brain-computer interface solutions.
• In May 2024, The USC Center for Neurotechnology, led by Maryam Shanechi, received a $5 million grant from the NIH BRAIN Initiative to enhance brain-computer interface systems aimed at treating mental health disorders.
• In January 2024, Motif Neurotech, a startup focused on neurotechnology, successfully closed an oversubscribed Series A financing round of $18.75 million to develop its DOT microstimulator, a device aimed at treating treatment-resistant depression.

Author: Ronit Sharma and Rishav Thakur

Customization Opportunities

At Roots Analysis, we genuinely care about your success and understand that your business requirements are unique. While our market research reports provide valuable insights, we recognize that they might not cover every aspect you need to make well-informed strategic decisions. To account for that, we offer 15% free report customization tailored to your specific needs. Whether you require additional quantitative analysis, qualitative insights, or any other information related to the neurotechnology market, reach out us today at: support@rootsanalysis.com